{"id":"plc","safety":{"commonSideEffects":[{"rate":"null","effect":"Hyperglycemia"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL3978833","moleculeType":"Small molecule","molecularWeight":"414.41"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"PLC works by inhibiting the PI3K/AKT pathway, which is involved in cell proliferation and survival. This inhibition leads to the reduction of tumor growth and metastasis.","oneSentence":"PLC is a drug that targets the PI3K/AKT pathway.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:29:12.259Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced solid tumors"}]},"trialDetails":[{"nctId":"NCT06907472","phase":"NA","title":"Diabetes Management for Primary Healthcare Centers.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Abuja","startDate":"2025-09-15","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":106},{"nctId":"NCT06174155","phase":"NA","title":"Comparative Study Between Botulinum Toxin-A Injection and Shock Waves on Hypertrophic Scars in Hand-burned Children","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-12-15","conditions":"Hand-burned Children","enrollment":60},{"nctId":"NCT03092895","phase":"PHASE2","title":"A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2017-04-24","conditions":"Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma","enrollment":157},{"nctId":"NCT04145141","phase":"","title":"National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-07-28","conditions":"Hepatocellular Carcinoma, Liver Cancer, Cholangiocarcinoma","enrollment":500},{"nctId":"NCT07345208","phase":"PHASE2, PHASE3","title":"Safety and Immunogenicity of ID vs IM Rabies Vaccine","status":"NOT_YET_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2025-12-15","conditions":"Rabies","enrollment":90},{"nctId":"NCT06967857","phase":"PHASE2","title":"Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression","status":"RECRUITING","sponsor":"Prof. Dr. Frank Behrens","startDate":"2025-05-15","conditions":"Attention-Deficit/Hyperactivity Disorder (ADHD), Depression - Major Depressive Disorder","enrollment":105},{"nctId":"NCT01944332","phase":"NA","title":"Gamete Treatment to Correct Fertilization Failure","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2007-09","conditions":"Infertility","enrollment":1200},{"nctId":"NCT07083635","phase":"PHASE2","title":"Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users","status":"RECRUITING","sponsor":"Chulalongkorn University","startDate":"2025-07-29","conditions":"Menstruation Disturbances, Metrorrhagia, Uterine Hemorrhage","enrollment":40},{"nctId":"NCT01514552","phase":"PHASE1","title":"The Use of Functional Confections in Promoting Oral Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2010-11","conditions":"Oral Health, Oral Cancer, Gum Disease","enrollment":36},{"nctId":"NCT05946044","phase":"NA","title":"The Osteoarthritis Prevention Study","status":"RECRUITING","sponsor":"Wake Forest University","startDate":"2024-03-21","conditions":"Osteoarthritis, Knee","enrollment":1230},{"nctId":"NCT05714553","phase":"PHASE1, PHASE2","title":"NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours","status":"TERMINATED","sponsor":"NuCana plc","startDate":"2023-03-08","conditions":"Advanced Cancer, Advanced Solid Tumor, Neoplasm Malignant","enrollment":19},{"nctId":"NCT06652698","phase":"NA","title":"Early Supplementation for Cow's Milk Allergy Prevention","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-07","conditions":"Food Allergy, Cow's Milk Allergy","enrollment":1000},{"nctId":"NCT04548843","phase":"PHASE1","title":"A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion","status":"WITHDRAWN","sponsor":"Minovia Therapeutics Ltd.","startDate":"2022-03-01","conditions":"Primary Mitochondrial Diseases","enrollment":""},{"nctId":"NCT06950606","phase":"NA","title":"Pneumatic Leg Compression and Norepinephrine Requirements in Patients Having Non-cardiac Surgery","status":"RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2025-05-19","conditions":"Hypotension During Surgery","enrollment":238},{"nctId":"NCT06990204","phase":"PHASE1","title":"Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)","status":"NOT_YET_RECRUITING","sponsor":"Gedeon Richter Plc.","startDate":"2025-06-06","conditions":"Hypertension","enrollment":56},{"nctId":"NCT06823856","phase":"PHASE1","title":"Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)","status":"COMPLETED","sponsor":"Gedeon Richter Plc.","startDate":"2025-05-11","conditions":"Diabetes Mellitus Type 2","enrollment":64},{"nctId":"NCT04913805","phase":"PHASE2","title":"Matching Perfusion and Metabolic Activity in HFpEF","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2021-10-11","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":53},{"nctId":"NCT06914648","phase":"NA","title":"The Dragon PLC Trial (DRAGON-PLC)","status":"RECRUITING","sponsor":"Maastricht University","startDate":"2025-04-01","conditions":"Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma","enrollment":358},{"nctId":"NCT06766500","phase":"PHASE1","title":"Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)","status":"COMPLETED","sponsor":"Gedeon Richter Plc.","startDate":"2025-01-20","conditions":"Diabetes Mellitus Type 2","enrollment":64},{"nctId":"NCT06792968","phase":"PHASE1","title":"Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)","status":"COMPLETED","sponsor":"Gedeon Richter Plc.","startDate":"2025-03-30","conditions":"Diabetes Mellitus Type 2","enrollment":64},{"nctId":"NCT02283788","phase":"PHASE1","title":"Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2007-03","conditions":"Epilepsy","enrollment":67},{"nctId":"NCT02172742","phase":"PHASE1","title":"The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2002-05","conditions":"Epilepsy","enrollment":13},{"nctId":"NCT06889506","phase":"NA","title":"Interleukin-4 in Pityriasis Lichenoides Chronica","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-04-01","conditions":"Pityriasis Lichenoides","enrollment":50},{"nctId":"NCT06885723","phase":"NA","title":"Use of Vibration Anesthesia Device in Intratympanic Injections","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2020-07-25","conditions":"Intratympanic Injections, Sudden Hearing Loss","enrollment":40},{"nctId":"NCT06396689","phase":"NA","title":"NapBiome: Targeting Gut Microbiota and Sleep Rhythm to Improve Developmental and Behavioral Outcomes in Early Childhood","status":"NOT_YET_RECRUITING","sponsor":"Petra Zimmermann","startDate":"2025-03-01","conditions":"Sleep Problem, Neurobehavioral Manifestations","enrollment":380},{"nctId":"NCT06756048","phase":"NA","title":"Effects of Rhomboid Intercostal Block on Postoperative Pain Management and Chronic Pain Incidence in Mastectomies","status":"COMPLETED","sponsor":"Koç University","startDate":"2023-11-27","conditions":"Mastectomy, Rhomboid Intercostal Block, Chronic Pain Following Surgical Procedure for Cancer","enrollment":90},{"nctId":"NCT04705935","phase":"","title":"Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2022-08-15","conditions":"Preterm Birth, Preterm Premature Rupture of Membrane, Preterm Labor","enrollment":83},{"nctId":"NCT00853866","phase":"PHASE4","title":"Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2009-01","conditions":"Cerebral Stroke","enrollment":12},{"nctId":"NCT03489018","phase":"PHASE4","title":"The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-03-21","conditions":"Pneumococcal Infection, Streptococcus Pneumoniae Infection, Invasive Pneumococcal Disease, Protection Against","enrollment":2100},{"nctId":"NCT06444555","phase":"NA","title":"Adolescent Nutrition in Girls in Burkina Faso and Ethiopia","status":"COMPLETED","sponsor":"University Ghent","startDate":"2024-05-28","conditions":"Nutrition Deficiency Due to Insufficient Food","enrollment":400},{"nctId":"NCT06517199","phase":"PHASE3","title":"Olanzapine for Cancer Related Anorexia-cachexia Syndrome","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2024-01-22","conditions":"Anorexia, Cachexia","enrollment":138},{"nctId":"NCT03537950","phase":"NA","title":"Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder","status":"COMPLETED","sponsor":"King's College London","startDate":"2016-08-22","conditions":"Autism Spectrum Disorder","enrollment":38},{"nctId":"NCT02783092","phase":"PHASE3","title":"A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy","status":"UNKNOWN","sponsor":"Antonio Waldo Zuardi","startDate":"2019-01-09","conditions":"Epilepsy","enrollment":126},{"nctId":"NCT02803502","phase":"NA","title":"Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?","status":"UNKNOWN","sponsor":"Brugmann University Hospital","startDate":"2017-01","conditions":"Hemophilia","enrollment":50},{"nctId":"NCT05860530","phase":"NA","title":"Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2021-05-10","conditions":"Neoplasms","enrollment":48},{"nctId":"NCT05265806","phase":"NA","title":"The Effects of Oxytocin Treatment on Social Touch","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2021-09-01","conditions":"Healthy","enrollment":180},{"nctId":"NCT05807152","phase":"NA","title":"Furosemide-induced Diuresis With Matched Dehydration Compared to Standard Diuretic Therapy in Patients With Acute Heart Failure and Overt Fluid Overload","status":"UNKNOWN","sponsor":"Centro Cardiologico Monzino","startDate":"2019-02-19","conditions":"Acute Decompensated Heart Failure","enrollment":170},{"nctId":"NCT05717946","phase":"PHASE2","title":"The Influence of Probiotic Supplementation on the Severity of Anxiety and Depressive Symptoms, as Well as the Function and Composition of Gut Microbiota, Metabolic, Inflammation, and Oxidative Stress Markers in Patients With Depression","status":"UNKNOWN","sponsor":"Medical University of Lodz","startDate":"2021-01-04","conditions":"Depression, Anxiety","enrollment":100},{"nctId":"NCT05346978","phase":"NA","title":"Nasturtium (Tropaeolum Majus L) Intake and Biochemical Parameters in Pre-diabetic Subjects in Bogota Colombia","status":"COMPLETED","sponsor":"Javeriana University","startDate":"2018-06-01","conditions":"Pre Diabetes","enrollment":10},{"nctId":"NCT05332106","phase":"PHASE1","title":"Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2022-03-12","conditions":"Bioequivalence","enrollment":10},{"nctId":"NCT01098032","phase":"PHASE3","title":"RenalGuard System and Contrast Media","status":"COMPLETED","sponsor":"Clinica Mediterranea","startDate":"2009-01","conditions":"Chronic Kidney Disease","enrollment":294},{"nctId":"NCT03148860","phase":"PHASE3","title":"Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA","status":"COMPLETED","sponsor":"Dr. Frank Behrens","startDate":"2016-12-15","conditions":"Psoriatic Arthritis","enrollment":186},{"nctId":"NCT05118451","phase":"NA","title":"A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2020-07-01","conditions":"Primary Liver Cancers","enrollment":420},{"nctId":"NCT04982120","phase":"NA","title":"Use of Repris Needle in Bladder Injection","status":"UNKNOWN","sponsor":"Uro-1 Medical","startDate":"2018-10-15","conditions":"Overactive Bladder Syndrome","enrollment":40},{"nctId":"NCT04946487","phase":"","title":"Effect of the Posterior Ligamentous Complex on the Adjacent Segments Degeneration After Lumbar Surgery","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-07-01","conditions":"Lumbar Spinal Stenosis","enrollment":80},{"nctId":"NCT04822012","phase":"","title":"Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2021-03-01","conditions":"SARS-CoV-2","enrollment":50},{"nctId":"NCT02506049","phase":"NA","title":"Laser Photocoagulation in Twin to Twin Transfusion Syndrome","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2010-04","conditions":"Twin to Twin Transfusion Syndrome","enrollment":1},{"nctId":"NCT02842710","phase":"NA","title":"Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma","status":"WITHDRAWN","sponsor":"University Hospital, Toulouse","startDate":"2016-06-04","conditions":"Emergencies","enrollment":""},{"nctId":"NCT03109925","phase":"PHASE2","title":"Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement","status":"UNKNOWN","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2017-06-02","conditions":"Benign Prostatic Hyperplasia","enrollment":23},{"nctId":"NCT04255732","phase":"NA","title":"Comparison of Wide-field Retinal Imaging","status":"UNKNOWN","sponsor":"Prim. Prof. Dr. Oliver Findl, MBA","startDate":"2020-08-07","conditions":"Retinal Disease","enrollment":30},{"nctId":"NCT01963429","phase":"NA","title":"Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2013-09-30","conditions":"Recurrent Small Hepatocellular Carcinoma, Residual Small Hepatocellular Carcinoma","enrollment":144},{"nctId":"NCT02950532","phase":"","title":"Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures","status":"COMPLETED","sponsor":"AO Clinical Investigation and Publishing Documentation","startDate":"2016-10","conditions":"Spinal Deformity, Spinal Fractures, Spinal Injuries","enrollment":60},{"nctId":"NCT04419155","phase":"","title":"ESCAP-2020-CPHG: Treatment Strategies Follow-up Implemented During the First Three Years Following Primary Lung Cancer (PLC) Diagnosed in KBP-2020-CPHG Cohort Patients","status":"UNKNOWN","sponsor":"Collège des Pneumologues des Hôpitaux Généraux","startDate":"2020-01-01","conditions":"Lung Cancer","enrollment":5000},{"nctId":"NCT04402099","phase":"","title":"Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020","status":"UNKNOWN","sponsor":"Collège des Pneumologues des Hôpitaux Généraux","startDate":"2020-01-01","conditions":"Lung Cancer","enrollment":10000},{"nctId":"NCT03297944","phase":"PHASE4","title":"Sedative-Anxiolytic Effects on Simulated Driving Performance","status":"COMPLETED","sponsor":"Marion Coe","startDate":"2017-09-15","conditions":"Psychomotor Impairment","enrollment":15},{"nctId":"NCT01803828","phase":"PHASE4","title":"REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2014-05","conditions":"Diabetic Cardiomyopathy, Diabetes Mellitus Type 2","enrollment":120},{"nctId":"NCT03985865","phase":"PHASE4","title":"IG vs ID Bitter Administration","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2017-03-02","conditions":"Obesity","enrollment":14},{"nctId":"NCT03183752","phase":"NA","title":"Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules","status":"COMPLETED","sponsor":"Hospital Universitário Clementino Fraga Filho","startDate":"2015-08-13","conditions":"Thyroid Nodule, Insulin Resistance","enrollment":28},{"nctId":"NCT03829839","phase":"PHASE1","title":"Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity","status":"COMPLETED","sponsor":"University Hospital, Bonn","startDate":"2016-03-03","conditions":"Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs","enrollment":120},{"nctId":"NCT00152464","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2002-03-20","conditions":"Dermatitis, Atopic","enrollment":514},{"nctId":"NCT01195883","phase":"NA","title":"Effect of Goal-directed Crystalloid Versus Colloid Administration on Major Postoperative Morbidity","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2010-11","conditions":"Postoperative Complications","enrollment":1102},{"nctId":"NCT02489669","phase":"NA","title":"Renal Insufficiency Following Contrast Media Administration Trial III","status":"UNKNOWN","sponsor":"Clinica Mediterranea","startDate":"2015-07-15","conditions":"Contrast Nephropathy","enrollment":700},{"nctId":"NCT03342222","phase":"PHASE3","title":"The Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction","status":"UNKNOWN","sponsor":"Central South University","startDate":"2017-11-20","conditions":"PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction","enrollment":120},{"nctId":"NCT00897663","phase":"","title":"Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2006-11","conditions":"Brain and Central Nervous System Tumors","enrollment":56},{"nctId":"NCT01026857","phase":"PHASE2","title":"Propionyl-L-Carnitine in Ulcerative Colitis","status":"COMPLETED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2006-05","conditions":"Ulcerative Colitis","enrollment":121},{"nctId":"NCT02601131","phase":"","title":"Post-transfusion Platelet Count","status":"COMPLETED","sponsor":"Region Skane","startDate":"2016-02","conditions":"Leukemia, Multiple Sclerosis","enrollment":80},{"nctId":"NCT02170376","phase":"PHASE1","title":"The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2011-09","conditions":"Parkinson's Disease (PD)","enrollment":80},{"nctId":"NCT02171195","phase":"PHASE1","title":"A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2000-07","conditions":"Epilepsy","enrollment":64},{"nctId":"NCT01520987","phase":"PHASE1","title":"Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2011-05","conditions":"Parkinson Disease","enrollment":105},{"nctId":"NCT02786043","phase":"PHASE1","title":"PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2015-06","conditions":"Peripheral Arterial Diseases","enrollment":12},{"nctId":"NCT02786069","phase":"PHASE1","title":"A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2015-06","conditions":"Peripheral Arterial Disease","enrollment":16},{"nctId":"NCT02767102","phase":"NA","title":"Bioavailability and Bioactivity of Red Wine Melatonin in Humans","status":"COMPLETED","sponsor":"University of Milan","startDate":"2014-07","conditions":"Bioavailability","enrollment":12},{"nctId":"NCT00849264","phase":"PHASE2","title":"Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients","status":"COMPLETED","sponsor":"Eastern Hepatobiliary Surgery Hospital","startDate":"2008-12","conditions":"Hepatocellular Carcinoma, Portal Vein Tumor Thrombus","enrollment":120},{"nctId":"NCT02711267","phase":"NA","title":"Bioequivalence of Topical Acyclovir in Healthy Volunteers","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2014-01","conditions":"Dermatologic Disorders","enrollment":36},{"nctId":"NCT01568047","phase":"PHASE2","title":"Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2010-02","conditions":"Parkinson's Disease","enrollment":40},{"nctId":"NCT02169414","phase":"PHASE1","title":"Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2010-02","conditions":"Parkinson's Disease (PD)","enrollment":74},{"nctId":"NCT02071810","phase":"PHASE1","title":"Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2008-04","conditions":"Parkinson's Disease (PD)","enrollment":34},{"nctId":"NCT01533116","phase":"PHASE1","title":"Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2009-03","conditions":"Parkinson Disease","enrollment":52},{"nctId":"NCT02169466","phase":"PHASE1","title":"Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2009-01","conditions":"Parkinson's Disease (PD)","enrollment":22},{"nctId":"NCT01227655","phase":"PHASE3","title":"Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2011-03","conditions":"Parkinson's Disease","enrollment":427},{"nctId":"NCT01568073","phase":"PHASE3","title":"Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With \"Wearing-off\" Phenomenon","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2011-03","conditions":"Parkinson's Disease","enrollment":600},{"nctId":"NCT01519284","phase":"PHASE1","title":"Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2009-11","conditions":"Parkinson Disease","enrollment":82},{"nctId":"NCT02169479","phase":"PHASE1","title":"Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2008-09","conditions":"Parkinson's Disease (PD)","enrollment":16},{"nctId":"NCT02507648","phase":"PHASE1","title":"A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)","status":"COMPLETED","sponsor":"Genuine Research Center, Egypt","startDate":"2013-03","conditions":"Healthy","enrollment":24},{"nctId":"NCT00160563","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)","status":"TERMINATED","sponsor":"UCB Pharma","startDate":"2004-06","conditions":"Asthma","enrollment":207},{"nctId":"NCT02169453","phase":"PHASE1","title":"Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2008-10","conditions":"Parkinson's Disease (PD)","enrollment":12},{"nctId":"NCT02169895","phase":"PHASE1","title":"Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2008-09","conditions":"Parkinson's Disease (PD)","enrollment":16},{"nctId":"NCT01568034","phase":"PHASE2","title":"A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2009-04","conditions":"Parkinson's Disease","enrollment":10},{"nctId":"NCT01520727","phase":"PHASE1","title":"A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2007-10","conditions":"Parkinson Disease","enrollment":64},{"nctId":"NCT02171234","phase":"PHASE1","title":"A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2001-02","conditions":"Epilepsy","enrollment":32},{"nctId":"NCT02013986","phase":"PHASE4","title":"Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children","status":"UNKNOWN","sponsor":"Du yi","startDate":"2013-09","conditions":"Congenital Hydronephrosis, Congenital Choledochal Cyst, Fracture","enrollment":30},{"nctId":"NCT00510822","phase":"PHASE2","title":"Cimicoxib for the Treatment of Major Depression (SECIM)","status":"COMPLETED","sponsor":"Affectis Pharmaceuticals AG","startDate":"2007-10","conditions":"Major Depression","enrollment":169},{"nctId":"NCT00809497","phase":"PHASE3","title":"A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2008-05","conditions":"Peripheral Arterial Disease","enrollment":239},{"nctId":"NCT00399919","phase":"PHASE3","title":"Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)","status":"COMPLETED","sponsor":"Sigma-Tau Research, Inc.","startDate":"2006-04","conditions":"Peripheral Vascular Diseases, Intermittent Claudication","enrollment":69},{"nctId":"NCT00403286","phase":"PHASE2","title":"A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Dey","startDate":"2006-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":457}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ANXIETY"},{"count":1,"reaction":"BLOOD PRESSURE DECREASED"},{"count":1,"reaction":"BRAIN OPERATION"},{"count":1,"reaction":"CHEST PAIN"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"DYSPEPSIA"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"GASTROINTESTINAL DISORDER"},{"count":1,"reaction":"HAIR TEXTURE ABNORMAL"},{"count":1,"reaction":"INSOMNIA"}],"_approvalHistory":[],"publicationCount":15174,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"phase_3","status":"active","brandName":"PLC","genericName":"PLC","companyName":"Sigma-Tau Research, Inc.","companyId":"sigma-tau-research-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PLC is a drug that targets the PI3K/AKT pathway. Used for Advanced solid tumors.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}